FreedomHolding

FreedomHolding

Key arguments in support of the idea. ▪ Rising natural gas prices. ▪ Undervaluation. Investment Thesis EQT Corporation is one of the largest natural gas producers in the US. Natural gas constitutes over 90% of the Company's hydrocarbon revenues, with LPG sales comprising 8% and oil contributing 2%. EQT Corporation operates solely in the US market, which...

FreedomHolding

Key arguments in support of the idea. • The Company’s services will be more demanded over time. • Comparative valuations imply growth potential. • Technical analysis. Investment Thesis Symbotic Inc. (SYM) is an automation technology company, providing robotics and technologies to improve the efficiency of retail and wholesale stores in the US. The Company...

FreedomHolding

Key arguments in support of the idea. • The Company’s supplies grow faster than on average in the market. • Modernization and expansion of production lines may lead to a boom in sales in 2025. Investment Thesis Rivian Automotive, Inc. (RIVN) is a US company that develops, manufactures and sells electric vehicles. The model range is presented by electric SUVs...

FreedomHolding

Key arguments in support of the idea. ▪ Rising Oil and Natural Gas Prices. ▪ High Dividend Yield. Investment Thesis Sabine Royalty Trust owns land plots with oil and natural gas fields in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas. SBR obtains royalties from companies that extract hydrocarbons on its lands. The Company was founded on...

FreedomHolding

Key arguments in support of the idea. • GM's ongoing buyback programs could significantly reduce the number of shares outstanding. • The Company's Q2 results are likely to come in above expectations. New car prices in the U.S. remain high. • Momentum effects could support further upside for the stock. Investment Thesis General Motors Company is one of the...

FreedomHolding

Key arguments in support of the idea ▪ Initial clinical data for CLN-619 are pending. Investment thesis Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of cancer. On 1 June, Cullinan Therapeutics will present data from a Phase I clinical trial of its CLN-619 drug. The results of early-phase...

FreedomHolding

Key arguments in support of the idea. • The Company's supplies may recover in the second half of the year. • STLA's valuation relative to its peers looks very cheap. • Completion of the 2024 share buyback program may support the stock. Investment Thesis Stellantis N.V. (STLA) is one of the largest automakers in North America and Europe, engaged in a full...

FreedomHolding

Key arguments supporting the idea - Investment banking activity resurgence powers big banks. - A wave of surprisingly good earnings reports may take the shareholders on a ride. - Technical support highlights positive risk balance. Investment thesis Houlihan Lokey, Inc. (NYSE: HLI) is a global investment bank with expertise in mergers and acquisitions,...

FreedomHolding

Key arguments in support of the idea. • Declining used car prices in the U.S. could weigh on the Company's sales. • Carvana's high debt burden remains a significant risk. Investment Thesis Carvana Co. (CVNA) is one of the largest online-only used-car retailers in the U.S. The Company performs almost all the functions a physical dealer would offer, including...

FreedomHolding

Key arguments in support of the idea. ▪ UNH stock has come under pressure from a series of adverse events, though Q1 earnings may improve investor sentiment regarding further UNH business growth potential. ▪ A good moment for buying, both fundamentally and technically. Investment Thesis UnitedHealth Group (UNH) engages in the provision of health...